← Back to Search

Arm 1 for Chronic Pain (INSPIRE Trial)

N/A
Waitlist Available
Led By Lauren McCormack, PhD, MSPH
Research Sponsored by RTI International
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 18 months
Awards & highlights

INSPIRE Trial Summary

This trial is comparing two ways to help people with chronic pain, who are also taking opioids, to improve function and manage pain.

INSPIRE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~18 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 18 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Reduction of opioid use
Secondary outcome measures
Pain interference on functioning
Physical functioning
Other outcome measures
Brief Pain Inventory
Depressive symptoms
Emotional distress
+8 more

INSPIRE Trial Design

2Treatment groups
Active Control
Group I: Arm 1Active Control1 Intervention
Arm 1 participants will receive guideline-concordant pharmacotherapy based on clinical guidelines for opioid therapy for chronic noncancer pain plus the Shared Decision Making (SDM) intervention during their opioid management visits.
Group II: Arm 2Active Control1 Intervention
Arm 2 participants will receive the guideline-concordant pharmacotherapy based on clinical guidelines for opioid therapy for chronic noncancer pain plus the Motivational Interviewing and Cognitive Behavioral Therapy for Chronic Pain (MI+CBT-CP) Intervention.

Find a Location

Who is running the clinical trial?

RTI InternationalLead Sponsor
188 Previous Clinical Trials
876,540 Total Patients Enrolled
2 Trials studying Chronic Pain
89 Patients Enrolled for Chronic Pain
Patient-Centered Outcomes Research InstituteOTHER
548 Previous Clinical Trials
29,995,810 Total Patients Enrolled
9 Trials studying Chronic Pain
6,764 Patients Enrolled for Chronic Pain
University of North Carolina Health Care SystemUNKNOWN

Media Library

Motivational Interviewing and Cognitive Behavioral Therapy for Chronic Pain Clinical Trial Eligibility Overview. Trial Name: NCT03454555 — N/A
Chronic Pain Research Study Groups: Arm 1, Arm 2
Chronic Pain Clinical Trial 2023: Motivational Interviewing and Cognitive Behavioral Therapy for Chronic Pain Highlights & Side Effects. Trial Name: NCT03454555 — N/A
Motivational Interviewing and Cognitive Behavioral Therapy for Chronic Pain 2023 Treatment Timeline for Medical Study. Trial Name: NCT03454555 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are geriatric individuals eligible for this trial?

"The latest clinical trial seeks to recruit patients between the age of 18 and 85. For those under 18, there are 33 different trials available while 362 studies target adults aged 65 and above."

Answered by AI

Is it possible for me to enroll in this medical experiment?

"This clinical trial is garnering 526 participants aged between 18-85 who are suffering from chronic pain. To be considered, they must have a documented history of CNCP; currently or in the recent past take an opioid medication with more than 20 mg/day morphine equivalent dose; regularly visit one of the participating clinics and providers within the last year."

Answered by AI

Are candidates able to join this clinical experiment presently?

"The clinical trial in question is no longer recruiting patients, as per information on the clinicaltrials.gov website – it was initially posted on June 21st 2019 and last edited July 7th 2022. However, 403 other trials are still open for enrolment at this time."

Answered by AI

Who else is applying?

What state do they live in?
North Carolina
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
What site did they apply to?
Duke University Health System
How many prior treatments have patients received?
3+
Recent research and studies
~91 spots leftby Apr 2025